Clinical Trials Directory

Trials / Sponsors / Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Academic / Other · 15 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
WithdrawnAPX005M in Patients With Recurrent Ovarian Cancer
Ovarian Cancer
Phase 22023-09-07
RecruitingPalliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)
Gynaecological Cancer
—2023-01-12
RecruitingCharacterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
—2022-12-01
Active Not RecruitingOlaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer
Ovarian Cancer
Phase 22021-12-15
WithdrawnTrial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent O
Ovarian Cancer
Phase 32019-12-01
WithdrawnRucaparib Maintenance Therapy in Advanced Cervical Cancer
Cervical Cancer
Phase 22019-10-01
CompletedTrial in Patients With Relapsed Ovarian Cancer
Ovarian Cancer
Phase 22018-05-14
CompletedTrial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
Endometrial Cancer
Phase 22017-02-15
CompletedCombination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer
Endometrial Cancer
Phase 22016-12-12
CompletedNiraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer
Ovarian Cancer
Phase 1 / Phase 22015-02-15
CompletedA Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
Ovarian Epithelial Cancer Recurrent
Phase 22004-06-01
CompletedExemestane in Advanced and Recurrent Endometrial Carcinoma
Endometrial Cancer
Phase 22004-03-01
CompletedChemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum an
Ovarian Cancer, Peritoneal Cancer, Cancer of the Fallopian Tube
Phase 32002-03-01
CompletedRadiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Endometrial Cancer
Phase 32000-01-01
CompletedPaclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Phase 31999-08-01